financetom
Business
financetom
/
Business
/
Arizona Metals 7% Higher as Raises $27 Million in Bought Deal Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Arizona Metals 7% Higher as Raises $27 Million in Bought Deal Offering
Dec 20, 2024 7:59 AM

10:33 AM EST, 12/20/2024 (MT Newswires) -- Arizona Metals ( AZMCF ) was up more than 7% at last look on Friday as it closed its bought deal public offering of near 15.93 million shares at $1.70 each, raising close to $27.1 million. This includes the partial exercise of the over-allotment option.

Proceeds will fund exploration expenditures at the Kay Mine Project and Sugarloaf Peak Property, both in Arizona, as well as for working capital and general corporate purposes.

Arizona Metals ( AZMCF ) was last seen up $0.11, to $1.62, on the Toronto Stock Exchange.

Price: 1.62, Change: +0.11, Percent Change: +7.28

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
MiNK Therapeutics Says Testicular Cancer Patient Achieves Remission After INKT Cell Therapy
MiNK Therapeutics Says Testicular Cancer Patient Achieves Remission After INKT Cell Therapy
Jul 11, 2025
10:53 AM EDT, 07/11/2025 (MT Newswires) -- MiNK Therapeutics ( INKT ) said Friday that a patient with metastatic, treatment-resistant testicular cancer achieved complete and durable remission following treatment with its investigational invariant natural killer, or iNKT, cell therapy. The company said the case involving a patient who was given a single infusion of MiNK's agenT-797 with nivolumab after previous...
Europe's Medicines Agency Lifts Temporary Age Restriction on Valneva's Chikungunya Vaccine
Europe's Medicines Agency Lifts Temporary Age Restriction on Valneva's Chikungunya Vaccine
Jul 11, 2025
10:55 AM EDT, 07/11/2025 (MT Newswires) -- The European Medicines Agency said Friday its safety committee is lifting the temporary restriction on Valneva's (VALN) chikungunya vaccine, Ixchiq, in people aged at least 65. The temporary restriction was put in place during the committee's review of the vaccine following reported serious side effects, the EMA said. The safety committee concluded regardless...
Delta Air Lines' Strong Premium Revenue Driving Upside to Q3, 2025 Outlook, BofA Securities Says
Delta Air Lines' Strong Premium Revenue Driving Upside to Q3, 2025 Outlook, BofA Securities Says
Jul 11, 2025
10:57 AM EDT, 07/11/2025 (MT Newswires) -- Delta Air Lines' ( DAL ) strong premium revenue in Q2 is driving upside to the company's Q3 and full-year 2025 outlook, BofA Securities said in a Friday note. The company reported its Q2 results Thursday and issued a Q3 outlook of $1.25 to $1.75 in adjusted earnings per share. Delta Air Lines...
Copyright 2023-2026 - www.financetom.com All Rights Reserved